Testing Effectiveness of a Peer-Led Intervention to Enhance Community Integration
Photovoice
1 other identifier
interventional
192
1 country
1
Brief Summary
We are conducting a randomized clinical trial (RCT) comparing the 10-week peer-led Photovoice program to services as usual (SAU) at a large publicly funded community mental health agency in Massachusetts. The control SAU condition will be enhanced with a 60-minute peer-led group educational session about understanding and coping with prejudice and discrimination. The 10-session, peer-led Photovoice program, designed to empower individuals with serious mental illness (SMI) to confront public prejudice and discrimination and reduce personal stigma (self-stigma and perceived stigma), was developed and pilot tested at our Center, with primary contributions from staff with a lived experience of mental illness. Development of the Photovoice program was guided by an adaptation of the stress-coping model, informed by recent research and conceptualizations of the effects of stigma on people with SMI. The stress-coping model explicates the mechanisms by which public stigma about mental illness can lead to personal stigma, which in turn has a negative impact on the person's mental health and psychosocial functioning. This model also identifies critical factors that contribute to personal stigma or protect against it, as well as more vs. less adaptive coping responses, that are the primary focus of the Photovoice program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 5, 2015
CompletedFirst Submitted
Initial submission to the registry
July 23, 2015
CompletedFirst Posted
Study publicly available on registry
July 27, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2019
CompletedResults Posted
Study results publicly available
April 10, 2020
CompletedApril 10, 2020
March 1, 2020
4 years
July 23, 2015
February 12, 2020
March 30, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Internalized Stigma of Mental Illness Scale, Change in Internalized Stigma
a 29-item, 4-point scale (strongly disagree to strongly agree) assesses behaviors, thoughts and feelings that are self-stigmatizing and includes alienation, stereotype endorsement, discriminatory experiences, social withdrawal, and stigma resistance subscales. Internal consistency is .9 and test-retest reliability is .92. Lower scores are better. The scale score is the average score on the 29 items, which are scored from 1-4. Lower scores signify less internalized stigma.
Baseline, post-treatment, 3 months post-treatment, 6 months post-treatment
Approaches to Coping With Stigma, Change in Coping With Stigma
is a 27-item, 4-point scale ranging from 1-4 (strongly disagree to strongly agree) measuring strategies to cope with stigma: secrecy, withdrawal, distancing, educating others, and challenging others. The average score of the items in the first three subscales will represent the index for Avoidant Coping and the average score of the items in the last two subscales - the index for Proactive Coping with Stigma. Internal consistency for subscales range: .63-.84. Lower scores are better on Avoidant Coping and higher scores are better on Proactive Coping.
Baseline, post-treatment, 3 months post-treatment, 6 months post-treatment
The Stigma Scale, Change in Perceptions of Stigma
is a 28 item, 5 point scale ranging from 0-4 (strongly disagree to strongly agree) measuring experienced and anticipated stigma. Internal consistency ranges from .85-.87 and test-retest reliability from .4 to .7. The scale score is the average score on all items. Lower scores are better.
Baseline, post-treatment, 3 months post-treatment, 6 months post-treatment
Heinrich's Quality of Life Scale-Client Version, Change in Quality of Life
This is a 21 item, semi-structured interview-based, rating of an individual's psycho-social functioning and satisfaction with various life domains. The score on each item ranges from 0-6 with higher scores indicating better functioning. The subscale scores are computed based on the average score of items included. We report below on the interpersonal functioning and intrapsychic foundations subscales.
Baseline, post-treatment, 3 months post-treatment, 6 months post-treatment
Temple University Community Participation Scale, Change in Community Participation
is a 26 item instrument measuring frequency of participation and importance of various community activities (e.g., movies, library). Test-retest reliability is .7 and internal consistency is .9. Higher scores are better. We provide below the results for cumulative days of participation in the last 30 days across the 26 activities included in the measure (tcpm\_days\_participated). The possible range for this measure is 0-780.
Baseline, post-treatment, 3 months post-treatment, 6 months post-treatment
Secondary Outcomes (4)
Brief Psychiatric Rating Scale, Change in Psychiatric Symptoms
Baseline, post-treatment, 3 months post-treatment, 6 months post-treatment
Scales of Psychological Well-Being, Change in Well-being
Baseline, post-treatment, 3 months post-treatment, 6 months post-treatment
Maryland Assessment of Recovery, Change in Perceptions of Recovery
Baseline, post-treatment, 3 months post-treatment, 6 months post-treatment
Personal Growth and Recovery Scale, Change in Perceptions of Growth and Recovery
Baseline, post-treatment, 3 months post-treatment, 6 months post-treatment
Study Arms (2)
Photovoice
EXPERIMENTALParticipants in this arm will attend a 10-week peer-led Photovoice program conducted in group format.
Enhanced Control
ACTIVE COMPARATORParticipants in this arm will attend a 60-minute peer-led group discussion on stigma and discrimination, and be eligible to participate in the 10-week Photovoice program after completing all study assessments.
Interventions
The 10-session, peer-led Photovoice program, designed to empower individuals with SMI to confront public prejudice and discrimination and reduce personal stigma (self-stigma and perceived stigma), was developed and pilot tested at our Center, with primary contributions from staff with a lived experience of mental illness. In the Photovoice sessions, participants will be given a workbook titled Combating Prejudice and Discrimination through Photovoice Empowerment. Peer leaders will facilitate discussions based on topics in the workbook. Participants will be given cameras and guidance on taking pictures and writing narratives descriptions about the pictures, specifically the ways in which the pictures relate to experiences of prejudice and discrimination.
The control SAU condition will be enhanced with a 60-minute peer-led manualized educational group session (Leaders' Guidelines and Handout for Participants are attached). It will provide participants with information about the nature of stigma and the laws in the U.S. that protect people with disabilities from discrimination. Participants will be engaged in a discussion about their use of different strategies for proactive coping with psychiatric stigma. This session will be co-led by the same peers who will be delivering the Photovoice program to the experimental group at relevant wave and study sites. Participants randomized to the enhanced Services as Usual control condition will be invited to join a Photovoice group once they complete the final 6-month follow-up assessment.
Eligibility Criteria
You may qualify if:
- Age 18years and older
- Diagnosis of serious mental illness
- Receiving services at agency where study is taking place
- Willing and able to give written consent
- Conversant in English
You may not qualify if:
- Prior exposure to Photovoice
- Cognitive disability
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Boston University
Boston, Massachusetts, 02215, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Zlatka Russinova
- Organization
- Boston University
Study Officials
- PRINCIPAL INVESTIGATOR
Zlatka Russinova, PhD
Boston University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Associate Professor
Study Record Dates
First Submitted
July 23, 2015
First Posted
July 27, 2015
Study Start
March 5, 2015
Primary Completion
February 15, 2019
Study Completion
February 15, 2019
Last Updated
April 10, 2020
Results First Posted
April 10, 2020
Record last verified: 2020-03